Claritev

Claritev FCF/Debt

The Free Cash Flow to Debt Ratio of Claritev (CTEV) as of Oct 15, 2026 is -0.27 %. In the previous year, Free Cash Flow to Debt Ratio was -0.23 % — a change of 15.01% (lower).

FCF/Debt

-0.27 %

YoY

15.01%

Last updated:

Free Cash Flow to Debt Ratio of Claritev is 2025 -0.27 % . Free Cash Flow to Debt Ratio of Claritev was 2024 -0.23 % . It decreases by 15.01% lower compared to the previous year.

The Claritev FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2019
4.04 USD
Jan 1, 2020
6.70 USD
Jan 1, 2021
6.54 USD
Jan 1, 2022
5.94 USD
Jan 1, 2023
1.38 USD
Jan 1, 2024
-0.23 USD
Jan 1, 2025
-0.27 USD
The Claritev FCF/Debt history
YEARFCF/DebtYoY
-0.27 %+15.01%
-0.23 %-116.80%
1.38 %-76.73%
5.94 %-9.16%
6.54 %-2.28%
6.70 %+65.84%
4.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp, listed under the ticker CTEV with ISIN US62548M2098, is a health care company headquartered in New York City, United States. The company has 3,000 employees and completed its initial public offering on February 10, 2020. Claritev Corp operates within the health care sector, focusing on providing healthcare cost management solutions. Its services include analytics-based approaches to identify over-charges in medical claims, negotiating fair reimbursement for out-of-network costs, and developing preferred provider networks through contracted discounts with healthcare providers. The company also offers payment and revenue integrity services designed to detect and correct improper or unnecessary charges before or after claims processing, as well as solutions to address underpaid premium dollars. Claritev Corp utilizes a software-as-a-service platform that processes and analyzes data using descriptive, predictive, and prescriptive analytics to support its services. The company's website is https://www.multiplan.us/. Claritev Corp is engaged in the delivery of data-driven solutions aimed at optimizing healthcare spending and improving financial outcomes for its clients in the health care industry. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Free Cash Flow to Debt Ratio of Claritev is -0.27 % in 2025.

Free Cash Flow to Debt Ratio of Claritev changed from -0.23 % to -0.27 %, representing a 15.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Claritev since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Claritev with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Claritev

All Key Metrics — Claritev